The hospital has acknowledged an error in documents it shared with the federal agency.
CMS conducted an inspection at MD Anderson at the end of August after a previously investigated patient death. It detailed its findings in a report made public in late October.
In the report, CMS identified deficiencies in nine of the 23 areas surveyed, as well as two more patient deaths attributable to the deficiencies. Now MD Anderson officials say one of those two deaths reported is false.
The patient at the center of the discrepancy between the hospital and federal authorities’ report is a 54-year-old brain cancer patient, who CMS described as having “an untoward reaction” to overdoses of anesthetic drugs injected into her scalp before scheduled radiation treatment. CMS reported the patient died in May, according to the Houston Chronicle.
“MD Anderson identified an error in documents shared with CMS that outlined that a patient death had occurred,” the cancer center said in a statement provided to the Becker’s. “Following an additional internal review, MD Anderson confirmed that the patient did not die and is still receiving care. MD Anderson is communicating with CMS accordingly.”
CMS did not take Becker’s calls for comment.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
